In the UK, assessment by NICE has concluded that further research needs to be completed on the clinical effectiveness of using TDM ELISA tests for TNF-alpha inhibitors in RA as there is currently insufficient evidence to recommend routine adoption of these tests (75). This evidence concerns the gene TNF and rheumatoid arthritis.